Resources for Researchers
NIH National Center for Biotechnology Information (NCBI)
The NIH National Center for Biotechnology Information advances science and health by providing access to biomedical and genomic information.
NIH Molecular Libraries Program
The Molecular Libraries Roadmap offers biomedical researchers access to the large-scale screening capacity, along with medicinal chemistry and informatics,necessary to identify chemical probes to study the functions of genes, cells, and biochemical pathways. This will lead to new ways to explore the functions of genes and signaling pathways in health and disease.
Network for Pancreatic Organ Donors with Diabetes (nPOD)
The Network for Pancreatic Organ Donors with Diabetes (nPOD) is a collaborative research project that supports diabetes investigators by providing, without cost, rare and difficult to obtain tissues from donors with type 1 and type 2 diabetes. Interested researchers are encouraged to apply to obtain nPOD tissues, or to request access to analyze cases in the nPOD Online Pathology site.
A dynamic, multi-purpose, real-world patient data platform designed to accelerate all aspects of drug and device development. T1D Exchange has established a unique model to speed better treatments, therapies and research for type 1 diabetes (T1D).
Team Science Toolkit
Developed by the National Cancer Institute’s (NCI) Science of Team Science (SciTS) team, the Team Science Toolkit is an interactive website where visitors can freely upload and download publicly available resources that support the practice and study of team science. The Toolkit connects professionals from many disciplines, providing a forum for sharing knowledge as well as tools to maximize the efficiency and effectiveness of team science initiatives.
A clinical trials network that conducts studies designed to evaluate new approaches to prevent or ameliorate Type 1 Diabetes. Researchers can submit proposals for clinical trial protocols, request biological samples through its Living Biobank initiative, or submit proposals for ancillary studies that complement the objectives of TrialNet studies.